UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1511) 1511
Newspaper Article (13) 13
Newsletter (6) 6
Publication (5) 5
Book Chapter (4) 4
Magazine Article (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1095) 1095
science & technology (1035) 1035
life sciences & biomedicine (1012) 1012
male (879) 879
losartan (715) 715
female (694) 694
losartan - therapeutic use (659) 659
hypertension - drug therapy (554) 554
middle aged (554) 554
antihypertensive agents - therapeutic use (461) 461
aged (422) 422
hypertension (397) 397
losartan - adverse effects (392) 392
animals (355) 355
blood pressure - drug effects (355) 355
adult (347) 347
losartan - pharmacology (333) 333
cardiovascular system & cardiology (324) 324
antihypertensive agents - adverse effects (316) 316
pharmacology & pharmacy (289) 289
treatment outcome (287) 287
angiotensin receptor antagonists (275) 275
losartan - administration & dosage (250) 250
angiotensin ii type 1 receptor blockers - therapeutic use (241) 241
drug therapy, combination (231) 231
double-blind method (227) 227
rats (227) 227
hypertension - physiopathology (208) 208
peripheral vascular disease (206) 206
angiotensin-converting enzyme inhibitors - therapeutic use (190) 190
drug therapy (188) 188
tetrazoles - therapeutic use (173) 173
angiotensin (165) 165
antihypertensive agents - administration & dosage (165) 165
blood pressure (157) 157
antihypertensive agents - pharmacology (151) 151
general & internal medicine (147) 147
cardiac & cardiovascular systems (146) 146
abridged index medicus (144) 144
medicine, general & internal (142) 142
angiotensin ii type 1 receptor blockers - pharmacology (136) 136
angiotensin ii type 1 receptor blockers - adverse effects (131) 131
angiotensin-converting enzyme inhibitors - adverse effects (126) 126
hypertension - complications (125) 125
biphenyl compounds - therapeutic use (122) 122
dose-response relationship, drug (119) 119
angiotensin ii (117) 117
tetrazoles - adverse effects (116) 116
renin-angiotensin system - drug effects (114) 114
prospective studies (113) 113
risk factors (113) 113
urology & nephrology (110) 110
medicine & public health (108) 108
aged, 80 and over (99) 99
time factors (99) 99
imidazoles - therapeutic use (97) 97
valsartan (94) 94
rats, sprague-dawley (93) 93
research (92) 92
angiotensin ii type 1 receptor blockers - administration & dosage (91) 91
hydrochlorothiazide - therapeutic use (91) 91
biphenyl compounds - adverse effects (89) 89
heart failure - drug therapy (89) 89
disease models, animal (86) 86
heart failure (86) 86
angiotensin ii - antagonists & inhibitors (83) 83
adolescent (81) 81
diabetes (81) 81
care and treatment (79) 79
dosage and administration (78) 78
rats, wistar (78) 78
imidazoles - adverse effects (76) 76
analysis (73) 73
hydrochlorothiazide (73) 73
kidney - drug effects (72) 72
randomized controlled trials as topic (72) 72
tetrazoles - pharmacology (72) 72
health aspects (70) 70
follow-up studies (69) 69
ace inhibitors (68) 68
angiotensin-converting enzyme inhibitors - pharmacology (68) 68
atenolol - therapeutic use (68) 68
internal medicine (68) 68
valine - analogs & derivatives (68) 68
hydrochlorothiazide - administration & dosage (67) 67
medicine (66) 66
rodents (66) 66
hypertrophy, left ventricular - drug therapy (65) 65
benzimidazoles - therapeutic use (64) 64
cardiology (64) 64
enalapril - therapeutic use (62) 62
losartan - pharmacokinetics (62) 62
hydrochlorothiazide - adverse effects (61) 61
imidazoles - pharmacology (61) 61
young adult (61) 61
biphenyl compounds - pharmacology (60) 60
clinical trials as topic (60) 60
pharmacology/toxicology (60) 60
diuretics (59) 59
physiology (57) 57
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1449) 1449
German (30) 30
Spanish (19) 19
Japanese (17) 17
Russian (14) 14
French (12) 12
Portuguese (8) 8
Chinese (5) 5
Danish (5) 5
Italian (5) 5
Swedish (4) 4
Czech (2) 2
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Norwegian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 02/2014, Volume 9, Issue 2, pp. 295 - 301
Journal Article
Journal Article
JAMA oncology, ISSN 2374-2437, 05/2019, Volume 5, Issue 7, pp. 1020 - 1027
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2013, Volume 369, Issue 20, pp. 1892 - 1903
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2014, Volume 371, Issue 22, pp. 2061 - 2071
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2009, Volume 361, Issue 1, pp. 40 - 51
.... Early blockade of the renin–angiotensin system did not modify nephropathy progression in patients with type 1 diabetes but had important effects in slowing retinopathy... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2008, Volume 358, Issue 23, pp. 2433 - 2446
Journal Article